Skip to main content
OpenTrials
Completed

NCT Number: NCT03393299

Impact of the Systematic Use of the Criteria STOPP/START in Short Stay Geriatric.

Assess the impact of the systematic use of STOPP/START tool during medication conciliation on the evolution of hospitalised elderly people's quality of life at 2 months.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Quality of Life Drug Use

Age range

75 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital La Porte Verte

Versailles, 78004, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with more than 75 years old
  • Hospitalized in geriatrics short-stay
  • Patient with a written informed consent
  • Patient with a social security scheme

Exclusion criteria

  • Severe dementia
  • Not able to respond to SF-12
  • Disease at final stage
  • Patient under legal protection (maintenance of justice, tutelage, legal guardianship)

Treatment and study plan

STOPP/START criteria

Procedure

software which helps to do the drug reconciliation

Primary outcomes

  1. SF-12 Quality of life scale

    Time frame: at inclusion and at 2 months

    The evolution of the hospitalised elderly people's quality of life at 2 months will be measured by the SF-12 scale.

Secondary outcomes

  1. Number of falls

    Time frame: at 2 months

    The number of falls during the two months following the inclusion will be collected for each patient.

  2. Proportion of patients rehospitalized

    Time frame: at 2 months

    The proportion of patients that have been rehospitalized (unscheduled hospitalization) during the two months following inclusion will be measured.

  3. Mortality

    Time frame: at 2 months

    The mortality during the two months following inclusion will be measured.

Sponsors and collaborators

Lead sponsor

Lille Catholic University

Other

Registry information

Official study title

Impact of the Systematic Use of the Criteria STOPP/START in Short Stay Geriatric: Study of Superiority, Randomized, Controlled, Prospective, Single Blind

Acronym: REVOR

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Jan 8, 2018
Registry last updated
Aug 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.